List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bacillary Dysentery (Shigellosis) - Overview
Bacillary Dysentery (Shigellosis) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Bacillary Dysentery (Shigellosis) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Bacillary Dysentery (Shigellosis) - Companies Involved in Therapeutics Development
Akthelia Pharmaceuticals Ltd
Chongqing Zhifei Biological Products Co Ltd
GlaxoSmithKline Plc
Immuron Ltd
Polyneuron Pharmaceuticals AG
Protein Potential LLC
Bacillary Dysentery (Shigellosis) - Drug Profiles
(shigella + typhoid) (Bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AKT-10081 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GSK-3536852A - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GVXNSD-133 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IMM-124E - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
infectious disease vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PN-109 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SC-599 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SF2a-TT15 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
shigella (bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
shigella [serotype 2a] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
shigella [strain 53G] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
shigella vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
shigella vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
shigella vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
shigella vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Shigetec - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Activate IL-10 for Bacterial Infections and Crohn's Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bacillary Dysentery (Shigellosis) - Dormant Projects
Bacillary Dysentery (Shigellosis) - Product Development Milestones
Featured News & Press Releases
Jul 29, 2013: GlycoVaxyn Secures CHF 5.1 Million Strategic Translation Award From the Wellcome Trust to Finance Clinical Development of Shigella Vaccine
Jan 27, 2012: IVI Granted Two U.S. Patents On Dysentery Vaccine Inventions
Oct 08, 2010: GlycoVaxyn Phase I Clinical Study Shows Positive Data With Shigella Dysenteriae Vaccine Candidate Against Severe Diarrheal Disease
Feb 23, 2010: GlycoVaxyn Initiates Phase I Clinical Study with Bioconjugate Vaccine
Feb 15, 2007: IVI Scientists Develop New Laboratory Animal Model For Shigella
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Bacillary Dysentery (Shigellosis), H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Bacillary Dysentery (Shigellosis) - Pipeline by Akthelia Pharmaceuticals Ltd, H1 2019
Bacillary Dysentery (Shigellosis) - Pipeline by Chongqing Zhifei Biological Products Co Ltd, H1 2019
Bacillary Dysentery (Shigellosis) - Pipeline by GlaxoSmithKline Plc, H1 2019
Bacillary Dysentery (Shigellosis) - Pipeline by Immuron Ltd, H1 2019
Bacillary Dysentery (Shigellosis) - Pipeline by Polyneuron Pharmaceuticals AG, H1 2019
Bacillary Dysentery (Shigellosis) - Pipeline by Protein Potential LLC, H1 2019
Bacillary Dysentery (Shigellosis) - Dormant Projects, H1 2019

List of Figures
Number of Products under Development for Bacillary Dysentery (Shigellosis), H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Number of Products by Targets, H1 2019
Number of Products by Stage and Targets, H1 2019
Number of Products by Mechanism of Actions, H1 2019
Number of Products by Stage and Mechanism of Actions, H1 2019
Number of Products by Routes of Administration, H1 2019
Number of Products by Stage and Routes of Administration, H1 2019
Number of Products by Molecule Types, H1 2019
Number of Products by Stage and Molecule Types, H1 2019

Companies Mentioned
• Akthelia Pharmaceuticals Ltd
• Chongqing Zhifei Biological Products Co Ltd
• GlaxoSmithKline Plc
• Immuron Ltd
• Polyneuron Pharmaceuticals AG
• Protein Potential LLC